| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
86,250,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
611,379 |
Avg
Vol: |
609,689 |
| 52
Week Range: |
$50.99 - $50.99 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zwanziger Ron |
Chairman, CEO & President |
• • – |
2006-12-19 |
4 |
OE |
$17.15 |
$3,658,455 |
I/I |
213,321 |
1,769,902 |
|
- |
|
| Teitel Dave |
Chief Financial OfficerOfficer |
• – – |
2006-12-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
679 |
|
- |
|
| Russell Jon |
VP, FinanceOfficer |
• – – |
2006-12-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
752 |
|
- |
|
| Piasio Roger |
Chief Scientific Officer-Binax |
• – – |
2006-11-29 |
4 |
AS |
$37.97 |
$759,406 |
I/I |
(20,000) |
14,764 |
|
- |
|
| Piasio Roger |
Chief Scientific Officer-Binax |
• – – |
2006-11-29 |
4 |
AS |
$37.95 |
$3,800,470 |
D/D |
(100,000) |
100,200 |
|
- |
|
| Goldberg Carol R |
Director |
– • – |
2006-08-03 |
4 |
OE |
$4.14 |
$9,936 |
D/D |
2,400 |
2,400 |
|
- |
|
| Levy John F |
Director |
– • – |
2006-08-02 |
4 |
OE |
$4.26 |
$10,224 |
D/D |
2,400 |
95,816 |
|
- |
|
| Toohey David |
Pres, Professional Diagnostics |
• – – |
2006-06-30 |
5 |
A |
$20.40 |
$10,608 |
D/D |
520 |
5,719 |
|
- |
|
| Hempel Paul T |
Sr VP, LD & Legal Affairs |
• – – |
2006-06-30 |
5 |
A |
$20.40 |
$7,487 |
D/D |
367 |
4,338 |
|
- |
|
| Yonkin John |
Pres., US Point of Care |
• – – |
2006-06-30 |
5 |
A |
$20.40 |
$6,814 |
D/D |
334 |
14,777 |
|
- |
|
| Eylenbosch Hilde |
President,Consumer Diagnostics |
• – – |
2006-06-21 |
4 |
B |
$0.00 |
$0 |
I/I |
25,000 |
25,000 |
1.91 |
- |
|
| Goldberg Carol R |
Director |
– • – |
2006-06-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,434 |
34,937 |
|
- |
|
| Mcaleer Jerome F |
VP, Research & Development |
• • – |
2006-06-09 |
4 |
OE |
$4.38 |
$43,800 |
D/D |
10,000 |
10,000 |
|
- |
|
| Piasio Roger |
Chief Scientific Officer-Binax |
• – – |
2006-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
40,764 |
|
- |
|
| Piasio Roger |
Chief Scientific Officer-Binax |
• – – |
2006-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200,200 |
|
- |
|
| Yonkin John |
VP, US OTC Sales |
• – – |
2005-12-31 |
5 |
A |
$20.15 |
$6,247 |
D/D |
310 |
14,443 |
|
- |
|
| Lindop Christopher J |
Chief Financial Officer |
• – – |
2005-12-31 |
5 |
A |
$20.15 |
$9,350 |
D/D |
464 |
1,939 |
|
- |
|
| Toohey David |
VP, Professional Diagnostics |
• – – |
2005-12-31 |
5 |
A |
$20.15 |
$8,503 |
D/D |
422 |
5,199 |
|
- |
|
| Hempel Paul T |
General Counsel & Secretary |
• – – |
2005-12-31 |
5 |
A |
$20.15 |
$7,516 |
D/D |
373 |
3,971 |
|
- |
|
| Scott David |
Chief Scientific Officer |
• • – |
2005-10-13 |
4 |
OE |
$0.75 |
$12,298 |
D/D |
13,000 |
5,200 |
|
- |
|
| Yonkin John |
VP, US OTC Sales |
• – – |
2005-06-30 |
5 |
A |
$21.58 |
$6,237 |
D/D |
289 |
14,133 |
|
- |
|
| Lindop Christopher J |
Chief Financial Officer |
• – – |
2005-06-30 |
5 |
A |
$21.58 |
$9,387 |
D/D |
435 |
1,475 |
|
- |
|
| Toohey David |
VP, Professional Diagnostics |
• – – |
2005-06-30 |
5 |
A |
$21.58 |
$8,697 |
D/D |
403 |
4,777 |
|
- |
|
| Hempel Paul T |
General Counsel & Secretary |
• – – |
2005-06-30 |
5 |
A |
$21.58 |
$7,488 |
D/D |
347 |
3,598 |
|
- |
|
| Goldberg Carol R |
Director |
– • – |
2005-06-16 |
5 |
GD |
$0.00 |
$0 |
I/I |
2,802 |
43,371 |
|
- |
|
500 Records found
|
|
Page 19 of 20 |
|
|
